New-onset depression among children, adolescents, and adults with hidradenitis suppurativa

被引:22
作者
Wright, Shari [1 ]
Strunk, Andrew [1 ]
Garg, Amit [1 ]
机构
[1] Donald & Barbara Zucker Sch Med Hofstra Northwell, Dept Dermatol, New Hyde Pk, NY 11042 USA
关键词
comorbidity; depression; Explorys; hidradenitis suppurativa; incidence; mood disorder; new-onset; QUALITY-OF-LIFE; METABOLIC SYNDROME; MAJOR DEPRESSION; PREVALENCE; DISEASE; ASSOCIATION; INSTRUMENTS; BURDEN;
D O I
10.1016/j.jaad.2020.05.090
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Information on the risk of depression among children, adolescents, and adults with hidradenitis suppurativa (HS) is limited. Objective: To compare the risk of new-onset depression in patients with HS with that of control individuals. Methods: Retrospective cohort analysis of 49,280 adult and 3042 pediatric patients with HS and matched control individuals identified by using electronic health record data. The primary outcome was incident depression. Results: The crude incidence rate was 4.8 per 100 person-years in adult patients with HS compared to 3.0 per 100 person-years in control individuals. Among pediatric patients, the crude incidence rate was 4.2 per 100 person-years in patients with HS compared with 2.3 per 100 person-years in control individuals. In adjusted analysis, adults and pediatric patients with HS had a 10% (hazard ratio, 1.10; 95% confidence interval, 1.07-1.13; P<.001) and 26% (hazard ratio, 1.26; 95% confidence interval, 1.10-1.44; P<.001), respectively, increased risk of developing depression compared to control individuals. Among patients with HS, factors associated with depression included female sex, white race, smoking, and body mass index/obesity in adults and pediatric patients and substance abuse in adults only. Limitations: Patients not seeking care in health systems within the database were not captured. Conclusion: Children, adolescents, and adults with HS are at an increased risk for developing depression, independent of other common risk factors for depression.
引用
收藏
页码:1360 / 1366
页数:7
相关论文
共 40 条
  • [1] [Anonymous], 2016, LIB YOUR HEALTHC DAT
  • [2] Brody Debra J, 2018, NCHS Data Brief, P1
  • [3] Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity
    Canoui-Poitrine, Florence
    Revuz, Jean E.
    Wolkenstein, Pierre
    Viallette, Cedric
    Gabison, Germaine
    Pouget, Florence
    Poli, Florence
    Faye, Ousmane
    Bastuji-Garin, Sylvie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (01) : 51 - 57
  • [4] Prevalence of depression, quality of life and antidepressant treatment in the Danish General Suburban Population Study
    Ellervik, Christina
    Kvetny, Jan
    Christensen, Kaj Sparle
    Vestergaard, Mogens
    Bech, Per
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2014, 68 (07) : 507 - 512
  • [5] Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease
    Farzanfar, Delaram
    Dowlati, Yekta
    French, Lars E.
    Lowes, Michelle A.
    Alavi, Afsaneh
    [J]. SKIN PHARMACOLOGY AND PHYSIOLOGY, 2018, 31 (05) : 246 - 251
  • [6] Systematic review and assessment of validated case definitions for depression in administrative data
    Fiest, Kirsten M.
    Jette, Nathalie
    Quan, Hude
    St Germaine-Smith, Christine
    Metcalfe, Amy
    Patten, Scott B.
    Beck, Cynthia A.
    [J]. BMC PSYCHIATRY, 2014, 14
  • [7] Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
    Garg, Amit
    Neuren, Erica
    Cha, Denny
    Kirby, Joslyn S.
    Ingram, John R.
    Jemec, Gregor B. E.
    Esmann, Solveig
    Thorlacius, Linnea
    Villumsen, Bente
    del Marmol, Veronique
    Nassif, Aude
    Delage, Maia
    Tzellos, Thrasyvoulos
    Moseng, Dagfinn
    Grimstad, Oystein
    Naik, Haley
    Micheletti, Robert
    Guilbault, Sandra
    Miller, Angie Parks
    Hamzavi, Iltefat
    van der Zee, Hessel
    Prens, Errol
    Kappe, Naomi
    Ardon, Christine
    Kirby, Brian
    Hughes, Rosalind
    Zouboulis, Christos C.
    Nikolakis, Georgios
    Bechara, Falk G.
    Matusiak, Lukasz
    Szepietowski, Jacek
    Glowaczewska, Amelia
    Smith, Saxon D.
    Goldfarb, Noah
    Daveluy, Steven
    Avgoustou, Christina
    Giamarellos-Bourboulis, Evangelos
    Cohen, Steven
    Soliman, Yssra
    Brant, Elena Gonzalez
    Akilov, Oleg
    Sayed, Christopher
    Tan, Jerry
    Alavi, Afsaneh
    Lowes, Michelle A.
    Carlos Pascual, Jose
    Riad, Hassan
    Fisher, Shani
    Cohen, Arnon
    Paek, So Yeon
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (02) : 366 - 376
  • [8] Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States
    Garg, Amit
    Papagermanos, Vassiliki
    Midura, Margaretta
    Strunk, Andrew
    Merson, Jonathan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : 495 - +
  • [9] Factors Associated With Point-of-Care Treatment Decisions for Hidradenitis Suppurativa
    Garg, Amit
    Besen, Justin
    Legler, Aaron
    Lam, Christina S.
    [J]. JAMA DERMATOLOGY, 2016, 152 (05) : 553 - 557
  • [10] The prevalence of metabolic syndrome in patients with hidradenitis suppurativa
    Gold, Daniel A.
    Reeder, Virginia J.
    Mahan, Meredith G.
    Hamzavi, Iltefat H.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (04) : 699 - 703